Mid-Morning Market Update: Markets Mostly Lower; Albertsons Tops Q2 Estimates

Following the market opening Monday, the Dow traded down 0.32% to 35,182.99 while the NASDAQ rose 0.12% to 14,915.84. The S&P also fell, dropping 0.06% to 4,468.81.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 45,792,530 cases with around 744,540 deaths. India confirmed a total of at least 34,081,310 cases and 452,320 deaths, while Brazil reported over 21,644,460 COVID-19 cases with 603,320 deaths. In total, there were at least 241,556,670 cases of COVID-19 worldwide with more than 4,915,950 deaths, according to data compiled by Johns Hopkins University.


Leading and Lagging Sectors


Energy shares gained by 1.3% on Monday. Meanwhile, top gainers in the sector included TORM plc TRMD, up 10% and PHX Minerals Inc. PHX up 13%.


In trading on Monday, utilities shares fell 1%.


Top Headline


Albertsons Companies, Inc. ACI reported better-than-expected results for its second quarter on Monday.

Albertsons reported quarterly earnings of $0.64 per share, beating analysts’ estimates of $0.45 per share. The company reported quarterly revenue of $16.50 billion, versus analysts’ estimates of $15.81 billion.

Albertsons also increased its quarterly dividend by 20% to $0.12 per share. The next quarterly dividend will be paid on November 12, 2021, to stockholders of record on October 29, 2021. Albertsons raised FY21 EPS guidance to $2.50 - $2.60 (previously $2.20 - $2.30) versus the consensus of $2.28. The company also raised adjusted EBITDA to $3.95 billion - $4.05 billion (prior view $3.7 billion - $3.8 billion).

 

Equities Trading UP


Valneva SE VALN shares shot up 35% to $37.83after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare.

Shares of Evolving Systems, Inc EVOL got a boost, shooting 19% to $2.67 after the company announced it will sell its activation and marketing businesses to PartnerOne Capital for $40 million.

Aerovate Therapeutics, Inc. AVTE shares were also up, gaining 20% to $17.04 after declining around 19% on Friday.

Check out these big movers of the day


Equities Trading DOWN

Revance Therapeutics, Inc. RVNC shares tumbled 41% to $13.50. The FDA issued a Complete Response Letter (CRL) regarding Revance Therapeutics’ marketing application for DaxibotulinumtoxinA for Injection for moderate to severe glabellar (frown) lines.


Shares of Omeros Corporation OMER were down 29% to $5.50 after the company announced it received a Complete Response Letter from the FDA for the Biologics License Application for narsoplimab in the treatment of HSCT-TMA.


Phathom Pharmaceuticals, Inc. PHAT was down, falling 19% to $26.49. Phathom Pharmaceuticals announced data from the PHALCON-EE Phase 3 trial evaluating vonoprazan versus lansoprazole for erosive esophagitis (EE).


Commodities

In commodity news, oil traded up 1.7% to $83.64, while gold traded down 0.4% to $1,761.80.


Silver traded down 0.3% Monday to $23.29 while copper rose 0.2% to $4.7375.


Euro zone

European shares were lower today. The eurozone’s STOXX 600 slipped 0.5%, the Spanish Ibex Index fell 0.7% and the German DAX 30 declined 0.6%. Meanwhile, the London’s FTSE 100 fell 0.3%, French CAC 40 dipped 0.9% and Italy’s FTSE MIB dropped 0.9%.


Economics


Industrial production dropped 1.3% in September, following a revised 0.1% drop in August.


The NAHB housing market index increased 4 points to a reading of 80 in October.


The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.


Federal Reserve Bank of Minneapolis President Neel Kashkari will speak at 2:15 p.m. ET.


The Treasury International Capital report for August will be released at 4:00 p.m. ET.

Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Morning Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!